Yes
It is.
No
It isn’t.
President Trump has signed a sweeping order imposing a 100 percent tariff on certain brand-name prescription drugs, aiming to address concerns about high drug prices and foreign pharmaceutical competition. Proponents say the policy could encourage domestic manufacturing and reduce reliance on overseas supply chains, while opponents warn it may drive up costs for consumers or lead to shortages. The decision puts a spotlight on the ongoing debate over healthcare affordability and economic strategy.